PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 76 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $11,000 | -38.9% | 18,144 | -32.4% | 0.00% | – |
| Q1 2017 | $18,000 | +100.0% | 26,848 | -10.3% | 0.00% | – |
| Q4 2016 | $9,000 | +125.0% | 29,926 | +201.9% | 0.00% | – |
| Q3 2016 | $4,000 | 0.0% | 9,911 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | 0.0% | 9,911 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -88.9% | 9,911 | -67.9% | 0.00% | – |
| Q4 2015 | $36,000 | +63.6% | 30,871 | +90.2% | 0.00% | – |
| Q1 2015 | $22,000 | -40.5% | 16,228 | -40.1% | 0.00% | -100.0% |
| Q3 2014 | $37,000 | -84.0% | 27,076 | -78.0% | 0.00% | -75.0% |
| Q2 2014 | $231,000 | +106.2% | 123,127 | +108.3% | 0.00% | +100.0% |
| Q1 2014 | $112,000 | -10.4% | 59,101 | -34.4% | 0.00% | 0.0% |
| Q4 2013 | $125,000 | -31.7% | 90,089 | -30.5% | 0.00% | -50.0% |
| Q3 2013 | $183,000 | +46.4% | 129,541 | +33.4% | 0.00% | +33.3% |
| Q2 2013 | $125,000 | – | 97,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delaney Dennis R | 60,000 | $25,000 | 0.05% |
| Freedom Investment Management, Inc. | 1,422,314 | $597,000 | 0.04% |
| Sterling Global Strategies LLC | 10,000 | $4,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,009,400 | $424,000 | 0.01% |
| CORRADO ADVISORS, LLC | 15,000 | $6,000 | 0.00% |
| First Heartland Consultants, Inc. | 17,240 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 37,955 | $16,000 | 0.00% |
| Commonwealth Equity Services, Inc | 486,961 | $205,000 | 0.00% |
| QS Investors, LLC | 503,400 | $212,000 | 0.00% |
| Perceptive Advisors | 24,332 | $10,000 | 0.00% |